Cargando…
Alvimopan in an Enhanced Recovery Program Following Radical Cystectomy
Background: Radical cystectomy (RC) carries a high complication rate, including post-operative ileus. Alvimopan is an FDA approved peripherally acting μ-opioid receptor antagonist that has shown favorable results for improved recovery of gastro-intestinal function resulting in decreased hospital len...
Autores principales: | Hamilton, Zach, Parker, Will, Griffin, Josh, Isaacson, Tanner, Mirza, Moben, Wyre, Hadley, Holzbeierlein, Jeffrey, Lee, Eugene K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929338/ https://www.ncbi.nlm.nih.gov/pubmed/27398398 http://dx.doi.org/10.3233/BLC-150017 |
Ejemplares similares
-
The July Effect in Radical Cystectomy: Mortality, Morbidity, and Efficiency
por: Zuk, Keegan, et al.
Publicado: (2016) -
Venous thromboembolism after radical cystectomy: Experience with screening ultrasonography
por: Murray, Katie M., et al.
Publicado: (2016) -
Alvimopan: A cost–effective tool to decrease cystectomy length of stay
por: Manger, Jules Powers, et al.
Publicado: (2014) -
Metastatic prostate cancer in the modern era of PSA screening
por: Fontenot, Philip A., et al.
Publicado: (2017) -
Alvimopan Addition to a Standard Perioperative Recovery Pathway
por: Itawi, Edward A., et al.
Publicado: (2011)